Toll-like receptors as novel therapeutic targets for ovarian cancer.
about
Redox Control of Multidrug Resistance and Its Possible Modulation by AntioxidantsGene silencing of Toll-like receptor 2 inhibits proliferation of human liver cancer cells and secretion of inflammatory cytokinesEvaluation of Toll-Like receptor 2 and 4 RNA expression and the cytokine profile in postmenopausal women with metabolic syndrome.Melatonin attenuates the TLR4-mediated inflammatory response through MyD88- and TRIF-dependent signaling pathways in an in vivo model of ovarian cancerIdentifying overlapping mutated driver pathways by constructing gene networks in cancer.Effects of TLR4 gene silencing on the proliferation and apotosis of hepatocarcinoma HEPG2 cells.TLR agonists: our best frenemy in cancer immunotherapyUpdates on artemisinin: an insight to mode of actions and strategies for enhanced global production.
P2860
Q26765805-43DD3D11-6A24-435C-966E-20FEF0878081Q34344636-639D7FC9-246E-4A23-84B0-6E63E1BA2590Q34361828-FFB7E644-A868-4A62-B91D-CDB02FFEC131Q35066004-4B75BCC6-0166-4A5B-97DE-0BB0DD60CCF7Q35477349-23CC0C3A-9E7F-45BF-A382-629F205E32A6Q36825783-108CD37F-185D-4C67-AA6D-BF708E135F17Q36850457-DE4A0159-A384-4F63-B050-E34E27C6FC55Q38392573-957A26C7-76DE-4A24-901E-D623AE614ADF
P2860
Toll-like receptors as novel therapeutic targets for ovarian cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Toll-like receptors as novel therapeutic targets for ovarian cancer.
@ast
Toll-like receptors as novel therapeutic targets for ovarian cancer.
@en
type
label
Toll-like receptors as novel therapeutic targets for ovarian cancer.
@ast
Toll-like receptors as novel therapeutic targets for ovarian cancer.
@en
prefLabel
Toll-like receptors as novel therapeutic targets for ovarian cancer.
@ast
Toll-like receptors as novel therapeutic targets for ovarian cancer.
@en
P2093
P2860
P356
P1433
P1476
Toll-like receptors as novel therapeutic targets for ovarian cancer.
@en
P2093
Fabian Benencia
Harika Nandigam
Leslee Sprague
Maria Muccioli
Michelle Pate
P2860
P304
P356
10.5402/2012/642141
P577
2012-03-04T00:00:00Z